Go offline with the Player FM app!
Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.
Manage episode 495651991 series 2739469
We love to hear from our listeners. Send us a message.
On this week's episode, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an ultra-lean drug development company to address an unmet need observed in his own patients as a surgeon: safe treatments for acute pain. Dr. Bazan explains his strategy for building value through small raises and no full-time salaried employees, co-founding the company with his father -- a scientist and director of the Neuroscience Center of Excellence at Louisiana State University Health Sciences Center -- and why the future of pain management will likely involve multimodal approached personalized to individual patients.
This episode of the Business of Biotech is brought to you by Ecolab.
Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
Chapters
1. Episode Introduction (00:00:00)
2. Dr. Bazan's Journey from Surgery to Biotech (00:06:11)
3. NIH Research Experience and Immunology Background (00:09:55)
4. Founding South Rampart Pharma (00:18:14)
5. Developing a Novel Pain Treatment (00:22:17)
6. Lean Operations and Fundraising Strategy (00:31:20)
7. The Pain Treatment Market Landscape (00:35:55)
8. Company Progress and Future Plans (00:41:33)
274 episodes
Manage episode 495651991 series 2739469
We love to hear from our listeners. Send us a message.
On this week's episode, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an ultra-lean drug development company to address an unmet need observed in his own patients as a surgeon: safe treatments for acute pain. Dr. Bazan explains his strategy for building value through small raises and no full-time salaried employees, co-founding the company with his father -- a scientist and director of the Neuroscience Center of Excellence at Louisiana State University Health Sciences Center -- and why the future of pain management will likely involve multimodal approached personalized to individual patients.
This episode of the Business of Biotech is brought to you by Ecolab.
Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
Chapters
1. Episode Introduction (00:00:00)
2. Dr. Bazan's Journey from Surgery to Biotech (00:06:11)
3. NIH Research Experience and Immunology Background (00:09:55)
4. Founding South Rampart Pharma (00:18:14)
5. Developing a Novel Pain Treatment (00:22:17)
6. Lean Operations and Fundraising Strategy (00:31:20)
7. The Pain Treatment Market Landscape (00:35:55)
8. Company Progress and Future Plans (00:41:33)
274 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.